We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.
- Authors
Naderi, M.; Dorgalaleh, A.; Alizadeh, S.; Kashani Khatib, Z.; Tabibian, S.; Kazemi, A.; Dargahi, H.; Bamedi, T.
- Abstract
The article presents a study on factor XIII (FXIII)-deficient patients with history of spontaneous intra cranial haemorrhage (ICH). The study aimed to shed light on the relationship of three common polymorphism of thrombin-activatable fibrinolysis inhibitor as auxiliary factors in the occurrence of ICH in FXIII deficiency. The involved patients were selected from the haemophilia centre in Zahedan, Iran with the largest population of patients with FXIII deficiency.
- Subjects
BLOOD coagulation factor XIII; HEMOGLOBIN polymorphisms; HEMORRHAGE; THROMBIN; ANTIFIBRINOLYTIC agents; HEMOPHILIACS; HEMOPHILIA; PATIENTS
- Publication
Haemophilia, 2014, Vol 20, Issue 1, pe89
- ISSN
1351-8216
- Publication type
Article
- DOI
10.1111/hae.12287